The association between PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Lipid Metabolism Disorder is reported, with clinical genetic testing available.
Sources1
Clinical variants0
Symptoms0
Compounds1
Trials7of 46 via PCSK9 compounds
Publications0
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.